A group of people

Key facts

AstraZeneca is a global, science led biopharmaceutical business. We are one of only a handful of companies to span the entire life-cycle of a medicine from research and development to manufacturing and supply, and the global commercialisation of primary care and speciality care medicines. We operate in more than 100 countries and our innovative medicines are used by millions of patients worldwide.

Our primary focus is on three important areas of healthcare: Cardiovascular and Metabolic disease (CVMD); Oncology; and Respiratory, Inflammation and Autoimmunity (RIA). We are also active in the Infection, Neuroscience and Gastrointestinal (ING) disease areas.

Key facts

  • We employ around 57,500 people worldwide: 32.7% in Europe, 23.5% in North America, 6.1% in Central and South America, 4.2% in the Middle East and Africa and 33.5% in Asia Pacific.
  • We manufacture in 16 countries and are committed to ensuring a reliable supply of medicines where and when they are needed.
  • We work in over 100 countries and our medicines are used by millions of patients worldwide.
  • Our revenue (CER) in 2014 totalled $26.095 billion

More facts are available in our 2014 Annual Report.

Annual Report 2014

AstraZeneca Annual Report 2014

Our Annual Report provides a wide range of information about our global business and how we are working, both within the company and in partnership with others, to meet complex healthcare challenges and deliver life-changing medicines for people worldwide.